Form 4: DBV Technologies Chief Medical Officer Sells Shares to Cover Tax Obligations

DBV Technologies' Chief Medical Officer, Pharis Mohideen, sold 600 ordinary shares at $0.85 per share to cover withholding tax obligations related to vesting restricted stock units.

Summary

• Pharis Mohideen, the Chief Medical Officer of DBV Technologies, sold 600 ordinary shares on January 30, 2025.
• The sale was executed at a price of $0.85 per share.
• The shares were sold to satisfy withholding tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Mr. Mohideen directly owns 110,510 ordinary shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, and is common in publicly traded companies.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The sale of 600 shares is a relatively small transaction and is unlikely to have a significant impact on the company's stock price.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price.

Key Dates

Keywords

DBV Technologies, Pharis Mohideen, Chief Medical Officer, share sale, insider trading, Form 4, restricted stock units, withholding tax